Geron Corporation GON.F Stock
Geron Corporation Price Chart
Geron Corporation GON.F Financial and Trading Overview
| Geron Corporation stock price | 3.39 EUR |
| Previous Close | 2.83 EUR |
| Open | 2.74 EUR |
| Bid | 2.75 EUR x 200000 |
| Ask | 2.78 EUR x 200000 |
| Day's Range | 2.74 - 2.74 EUR |
| 52 Week Range | 1.13 - 3.52 EUR |
| Volume | 78 EUR |
| Avg. Volume | 157 EUR |
| Market Cap | 1.39B EUR |
| Beta (5Y Monthly) | 0.895774 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.32 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.2 EUR |
GON.F Valuation Measures
| Enterprise Value | 1.21B EUR |
| Trailing P/E | N/A |
| Forward P/E | -6.5190477 |
| PEG Ratio (5 yr expected) | -0.83 |
| Price/Sales (ttm) | 2819.8462 |
| Price/Book (mrq) | 4.271451 |
| Enterprise Value/Revenue | 2456.704 |
| Enterprise Value/EBITDA | -8.11 |
Trading Information
Geron Corporation Stock Price History
| Beta (5Y Monthly) | 0.895774 |
| 52-Week Change | 166.90% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.52 EUR |
| 52 Week Low | 1.13 EUR |
| 50-Day Moving Average | 2.48 EUR |
| 200-Day Moving Average | 2.46 EUR |
GON.F Share Statistics
| Avg. Volume (3 month) | 157 EUR |
| Avg. Daily Volume (10-Days) | 445 EUR |
| Shares Outstanding | 508.77M |
| Float | 449.67M |
| Short Ratio | N/A |
| % Held by Insiders | 0.12% |
| % Held by Institutions | 44.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -30357.69% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.075% |
| Return on Equity (ttm) | -70.79% |
Income Statement
| Revenue (ttm) | 494K EUR |
| Revenue Per Share (ttm) | 0.001 EUR |
| Quarterly Revenue Growth (yoy) | -82.89% |
| Gross Profit (ttm) | -93668000 EUR |
| EBITDA | -149636992 EUR |
| Net Income Avi to Common (ttm) | -149924992 EUR |
| Diluted EPS (ttm) | -0.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 380.74M EUR |
| Total Cash Per Share (mrq) | 0.75 EUR |
| Total Debt (mrq) | 55.84M EUR |
| Total Debt/Equity (mrq) | 17.13 EUR |
| Current Ratio (mrq) | 8.814 |
| Book Value Per Share (mrq) | 0.641 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -139770000 EUR |
| Levered Free Cash Flow (ttm) | -87059504 EUR |
Profile of Geron Corporation
| Country | Germany |
| State | CA |
| City | Foster City |
| Address | 919 East Hillsdale Boulevard |
| ZIP | 94404 |
| Phone | 650 473 7700 |
| Website | https://www.geron.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 107 |
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Q&A For Geron Corporation Stock
What is a current GON.F stock price?
Geron Corporation GON.F stock price today per share is 3.39 EUR.
How to purchase Geron Corporation stock?
You can buy GON.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Geron Corporation?
The stock symbol or ticker of Geron Corporation is GON.F.
Which industry does the Geron Corporation company belong to?
The Geron Corporation industry is Biotechnology.
How many shares does Geron Corporation have in circulation?
The max supply of Geron Corporation shares is 596.99M.
What is Geron Corporation Price to Earnings Ratio (PE Ratio)?
Geron Corporation PE Ratio is now.
What was Geron Corporation earnings per share over the trailing 12 months (TTM)?
Geron Corporation EPS is -0.32 EUR over the trailing 12 months.
Which sector does the Geron Corporation company belong to?
The Geron Corporation sector is Healthcare.